TRACE INITIATIVE: Overview

Slides:



Advertisements
Similar presentations
Monitoring and Evaluation of VCT programs
Advertisements

An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
Inputs to a case-based HIV surveillance system. Objectives  Review HIV case definitions  Understand clinical and immunologic staging  Identify the.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
eHARS to CAREWare Pilot Project Update and Training
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
STRATEGIC INFORMATION FOR ACTION IN VIET NAM 6 th Viet Nam National Scientific Conference 24 November 2015 Ha Noi, Viet Nam Amitabh Bipin SUTHAR, PharmD,
Improving health worldwide Implications for Monitoring of the HIV Care Cascade? Jim Todd MeSH Satellite Session IAS Durban, Monday 18 th.
2013 HIV/AIDS Surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Boston University Slideshow Title Goes Here District Prevalence of Unsuppressed HIV in South African Women: Monitoring Programme Performance and Progress.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
LOW HCV PREVALENCE AMONG HIV+ INDIVIDUALS IN SUB-SAHARAN AFRICA
The CQUIN Learning Network: Partnering to Advance Differentiated Care
New WHO Guidelines on Person centred monitoring
State Office of AIDS Update
Ladies and gentlemen, On behalf of my country, the Republic of Côte d’Ivoire, I want to tell you how very pleased I am to be part of this high-level meeting,
Continuum of Surveillance Updates from Epidemiological Services New Jersey Department of Health Division of HIV, STD and TB Services (DHSTS) Annual.
Overview of recommended indicators for routine monitoring of iCCM
Addressing the challenges and successes of expediting TB treatment among PLHIV who are seriously ill: experience from Kenya Masini E & Olwande C National.
TB- HIV Collaborative activities in Romania- may 2006 status
Bhutan Last updated: September 2016.
Zimbabwe’s shift towards treat all: national country context
Using programme M&E data for Surveillance in Nepal: Challenges and Opportunities Name of Author(s): Biwesh Ojha(1)
HIV Care Continuum in Manhattan
Sierra Leone NPHA: CHAMPS
California Clinical Laboratory Association
Adolescents (10-19 yr) Last updated: October 2017.
Application of Geographic Information System (GIS) Technology to Improving Nigeria PEPFAR Program Presented by Amobi Andrew Onovo.
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
Find and Treat All Missing Persons with TB
WHO HIV update July 2018 Global epidemic Global progress and cascade
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS Surveillance in Europe
From toward HIV Elimination with Boosted-Integrated Active HIV Case Management (B-IACM) in Cambodia Dr. Penh Sun LY, Director, NCHADS Presented.
Bhutan.
Needs Assessment Slides for Module 4
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Diagnosis and Management of Acute HIV
TRACE INITIATIVE: Data Use
Hello! I am xxx I am here because I love to give presentations.
TRACE INITIATIVE: Data Management
TRACE INITIATIVE: Practical Scenarios
Bhutan Last updated: July 2018.
TRACE INITIATIVE: HIV Testing Services (HTS)
TRACE INITIATIVE: Risk Factor Questionnaire
Performing Sedia Asante: Testing algorithm
TRACE INITIATIVE: Returning of Recency Test Results
TRACE INITIATIVE: Data Collection Tools and Forms
Overview of RTRI: Assay Principle and Test Performance
Performing Maxim Swift RIA: Testing algorithm
Multi-disease diagnostic integration
Japan Last updated: April 2019.
Illustrative Cluster Detection and Response Strategy
Rose Nyirenda Ministry of Health, Malawi
Tracking with Recency Assays to Control the Epidemic (TRACE) Public Health Surveillance and Response : Using Data for Action.
Stakeholder engagement and research utilization: Insights from Namibia
Why PEPFAR Is Going All In on Partner Notification Services
HIV Recency Testing Preliminary experiences from Vietnam
Target-Setting, Impact and Resource Needs
Surveillance and Public Health Response using Recency: Early Evidence from the Field Getachew Tollera.
HIV Recency Testing in Rwanda
Importance of Data Quality for National HIV Prevention Program Monitoring and Evaluation Presented by: Guoshen Wang, MS Shubha Rao, MPH; Hui Zhao, MS;
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

TRACE INITIATIVE: Overview

Hello! I am xxx I am here because I love to give presentations. You can find me at: @username

BACKGROUND

36.7 million 16% decline 45% decline Global HIV Epidemic 36.7 million Estimated PLHIV globally, with ~1.8 million new infections having occurred in 2016. 16% decline In annual new infections between 2010 and 2016. 45% decline In AIDS-related deaths from 2005 to 2016 due to widespread ART coverage.

Estimated PLHIV in [country], with XX million on treatment as of XXXX. [Insert Country] HIV Epidemic XX million Estimated PLHIV in [country], with XX million on treatment as of XXXX. XX% Prevalence among adults (age 15-64). XX% Annual incidence among adults (age 15-64) or about X per 100 adults get infected each year.

As countries move closer to reaching “95-95-95,” real-time monitoring of recent HIV infections will allow targeting of the public health response.

Effective Epidemic Control Requires Early Detection and Quick Response Interrupt further transmission Target prevention Analyze data in real time (who/where/why) Detect Recent Infections Rapid Test for Recent Infection

Laboratory Tests for Recent Infection Antibody-based tests for recent infection (TRI) can distinguish recent from long-term HIV infection. Interpretation is challenged by factors that can cause ‘false-recent’ results: Variable immune responses at the individual-level, Variable performance of the assay across diverse HIV-1 subtypes and across populations with naturally low viral loads, Current ART use and advanced HIV disease. To improve accuracy of interpretation, recent infection testing algorithms (RITAs) incorporate the TRI result with other markers of chronic infection (e.g., low viral load, evidence of treatment).

Point-of-Care (POC) Tests for Recent Infection A POC assay using a single test device provides results within minutes and can simultaneously: diagnose HIV infection, and differentiate between recent and long-term infection. Evaluations of the POC test provide preliminary data on: diagnostic accuracy of the test, and mean duration of recent infection detected by the test: ~6 months. POC tests pave the way for a HIV recent infection surveillance system as part of routine HIV testing services (HTS) to detect and characterize recent HIV infection among newly diagnosed HIV cases.

Detecting Recent HIV-1 Infection > Antibody Avidity Antibody avidity = binding strength of antibody (how strongly HIV antibodies bind to HIV) Functional property of maturing antibodies Antibody avidity increases over time after infection Surrogate marker of time since infection Can be used to detect and distinguish recently infected persons (weak antibodies) from those with long-term infections (strong antibodies) Time >> Antibody Avidity >>

Limiting Antigen & Antibody Avidity 2012

Recent infection testing among newly diagnosed PLHIV leverages existing systems for added public health and programmatic benefit National HIV testing algorithm HTS Client Routine case finding strategies National surveillance systems National M&E systems Rapid Test 1 Report NEGATIVE Non Reactive Reactive Rapid Test 2 INDETERMINATE (Follow country guidelines) Non Reactive Reactive Report POSITIVE Test for recent infection Tested Recent Tested Long-term Supplementary test for recent infection among newly diagnosed Viral Load Test Confirmed recent (Tested recent + VL≥1,000 copies/mL) Report RECENT

RATIONALE

Rationale Data on recent infections will be used to: Strengthen partner notification to reduce number of new HIV infections Identify areas of high transmission for prevention programming Strengthen laboratory programs and other interventions in high burden locales to reduce HIV incidence Generate epidemiologic data to track the epidemic and measure HIV incidence (the rate of new infections)

Rationale Information on recent infections is valuable to patients and partner notification services: Recently infected individuals have high HIV viral loads and are more likely to transmit the virus to partners They should be treated as soon as possible to improve their health, and to reduce their risk of transmission to their sexual partner(s) and babies

Objectives and Goal First Objective Second Objective Goal 1. Monitor trends in the proportion testing recent on the RITA among newly diagnosed PLHIV by select demographic and HIV risk variables (as available on HIV case reporting form) to inform targeted HIV prevention interventions Second Objective 2. Identify geographic locations associated with testing recent on the RITA to inform geographic prioritization of HIV prevention interventions Goal Use a POC test for recent infection to provide continuous epidemiological data on person, place, and time of newly diagnosed individuals to inform HIV prevention and control strategies

Protocol Development There is a generic protocol: “Establishing HIV-1 Recent Infection Surveillance Using a Point-of-Care Test for Recent Infection among Persons Newly Diagnosed with HIV Infection in [Country]” 15-page protocol 6 appendices: Informed Consent Form Example Recent HIV Infection Surveillance Register Counseling procedures and messages for return of test results Information Sheet Statement of intent to maintain confidentiality Example analysis table shell Protocol and forms must be tailored to each country

SENSITIZATION

Sensitization Recent infection surveillance can be used: To triage partner and index testing to increase the yield of HTS To identify transmission clusters and develop program and prevention response plans Monitor success towards reducing new infections Support case reporting

Shift to Case Reporting Rapid Test for Recent Infection Can be deployed at HIV testing sites (HTS) As an addition to the existing national algorithm Focus on newly diagnosed HIV-positive individuals Recency data can be compiled and analyzed in real-time Program: Large number of persons being tested, coupled with index testing, can yield more # of recent infections Example Country M: 1M tested>10% prevalence>100,000 HIV- Positive>60,000 new diagnosis>3,000 to 6,000 recent infections Key issue Deduplication and identifying those 1) with prior diagnosis and 2) on ART HIV case-reporting system needed with unique ID

Shift to Case Reporting Key Objectives Identify recent infections (<1 year) among all newly diagnosed HIV-positive persons Develop a case-based surveillance system for all HIV- positive cases to strengthen recency surveillance Examine correlates of recent infections describing persons, place, and time Develop a targeted response for populations with high # of recent infections to interrupt further transmission of HIV Monitor trends of recent infections over time as a proportion of persons at-risk and newly diagnosed persons

Project Update (by country) Next steps (e.g. protocol development and approval process, procurement, panel preparation and laboratory TOT, implementation, etc.)

Project Timeline (by country) District A Districts B & C District D, E, & F March 10 20 7 April 30 15 May 5 24 16

Reporting Context New PEPFAR MER indicator: HTS_RECENT Percentage of persons aged ≥15 years newly diagnosed with HIV-1 infection who have a test for recent infection result of recent infection during the reporting period Reporting: Frequency: quarterly Level: facility and community Numerator Denominator Number of newly diagnosed HIV-positive persons aged ≥15 years with a test for recent infection result of recent infection during the past quarter Number of newly diagnosed HIV-positive persons aged ≥15 years with a test for recent infection result during the past quarter

Stakeholders’ Roles and Responsibilities MOH Owns data, provides technical oversight, provides staff for data collection and testing, and disseminates key findings CDC and USAID Provides technical support in design, implementation, analysis and use of findings Health facilities Specimen collection and transport Implementing partners and TA Support the roll-out Laboratories Specimen receipt, testing, and return of results

Questions? Comments?

Thank You!